High-resolution label-free vascular imaging using a commercial, clinically approved dermatological OCT scanner

R. A. Byers; G. Tozer; N. J. Brown; S. J. Matcher

doi:10.1117/12.2212222

29 February 2016 High-resolution label-free vascular imaging using a commercial, clinically approved dermatological OCT scanner

R. A. Byers, G. Tozer, N. J. Brown, S. J. Matcher

Author Affiliations +

Proceedings Volume 9689, Photonic Therapeutics and Diagnostics XII; 96890M (2016) https://doi.org/10.1117/12.2212222
Event: SPIE BiOS, 2016, San Francisco, California, United States

Abstract

Background and Aim: Recently developed decorrelative techniques such as speckle-variance optical coherence tomography (svOCT) have demonstrated non-invasive depth-resolved imaging of the microcirculation in-vivo. However, bulk tissue motion (BTM) originating from the subject's breathing or heartbeat remains problematic at low imaging speeds, often resulting in full frame decorrelation and a loss of vascular contrast. The aim of this study was to build upon existing svOCT techniques through utilisation of a commercially available, probe-based VivoSight OCT system running at 20 kHz Axial-scan rate. Methods and results: Custom four-dimensional scanning strategies were developed and utilised in order to maximise the interframe correlation during image acquisition. Volumes of structural OCT data were collected from various anatomical regions and processed using the aforementioned svOCT algorithm to reveal angiographic information. Following data collection, three dimensional image registration and novel filtering algorithms were applied to each volume in order to ensure that BTM artefacts were sufficiently suppressed. This enabled accurate visualisation of the microcirculation within the papillary dermis, to a depth of approximately 2mm. Applications of this technique, including quantitative capillary loop density measurement and visualisation of wound healing are demonstrated and enhanced through widefield mosaicing of the svOCT data. Conclusions: Non-invasive microcirculation imaging using an FDA 510(k) approved OCT scanner such as the VivoSight allows direct clinical utilisation of these techniques, in particular for the pathological analysis of skin diseases. This research was supported by BBSRC Doctoral Training Grant: BB/F016840/1. The authors also gratefully acknowledge the use of equipment funded by MRC grant: MR/L012669/1.

Conference Presentation

Citation Download Citation

R. A. Byers, G. Tozer, N. J. Brown, and S. J. Matcher "High-resolution label-free vascular imaging using a commercial, clinically approved dermatological OCT scanner", Proc. SPIE 9689, Photonic Therapeutics and Diagnostics XII, 96890M (29 February 2016); https://doi.org/10.1117/12.2212222

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available